Loading the player...
Information
Migraine vs. Headache: Whats the Difference
Length: 1:08
First presented at the Florida Osteopathic Medical Association. FOMA is proud to offer this on-demand CME program as Daniel Kassicieh, DO, FAAN, FACN discusses the difference between Migraine vs. Headache and prevention treatment.
Learning Objectives:
Awareness of the Need for Aggressive Migraine& Headache Prevention Treatment
Understand Migraine vs. Generic Headaches (including Chronic Daily Headaches) What specific characteristics define migraine headache disorder
What causes Generic Headaches
Classification of Migraine
Migraine Treatment versus Generic Headache Treatment PREVENTION– Primary Objective
Abortive – secondary consideration
21st Century Class of Migraine Prevention/Abortive Drugs
Dr. Kassicieh has no actual or potential conflict of interest in relation to this program or presentation.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Florida Osteopathic Medical Association (FOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
GRIEVANCE POLICY: The FOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to FOMA Executive Director Steve Winn, by calling the FOMA Office at 850-878-7364 or by mail to FOMA, 2544 Blairstone Pines Drive, Tallahassee, FL 32301, or by email to admin@foma.org
Daniel Kassicieh, DO, FAAN, FACN
Daniel Kassicieh, DO, FAAN, FACN, is a dual-board certified neurologist and is the medical director of the Florida Headache Center. He has been practicing Headache Medication in Sarasota for over 25 years. Dr. Kassicieh is a Fellow in both the American Academy of Neurology and American College of Neuropsychiatrists. Both of these honors were awarded to him on the basis of his extensive research experience, medical publications and continued support of headache/migraine patients and their families who are affected with neurological disorders. He was the founder and medical director of Neurological Research Institute of Sarasota. NRIS specialized in doing Phase 3B studies, including triptans and Botox treatment for migraine. Dr. Kassicieh’s primary medical interests are in the treatment of migraine and other headache disorders. He has lectured extensively on diagnosis, treatment and management of patients suffering from migraines and chronic headache disorders.
